ZURA - Zura Bio Ltd
1.21
-0.050 -4.132%
Share volume: 124,568
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.26
-0.05
-0.04%
Summary score
33%
Profitability
35%
Dept financing
23%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-9.74%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
21.43%
Debt ratio change over timeo
0%
Current Ratio
9.28%
Quick Ratio
0%
Cash Position Ratio
9.21%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-8.84%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
18.5%
Debt ratio change over timeo
0%
Current Ratio
9.96%
Quick Ratio
0%
Cash Position Ratio
9.88%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-11.16%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
19.88%
Debt ratio change over time
0%
Current Ratio
8.14%
Quick Ratio
0%
Cash Position Ratio
8.09%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | ZURA | AMGN | GILD | BNTX |
---|---|---|---|---|
Return on equity | 0% | 18.97% | 6.3% | 14.13% |
Return on assets | -9.74% | 3.05% | 3.04% | 13.28% |
Return on sales | 0% | 29.08% | 27.81% | 1.7% |
Return on invested capital | 0% | 5.17% | 3.5% | -46.9% |
Profitability | 0% | 81% | 55% | 45% |
Total debt ratio | 21.43% | 92.73% | 66.91% | 19.17% |
Debt ratio change over time | 0% | 21.88% | 144.36% | -1.07% |
Dept financing | 6% | 29% | 43% | 5% |
Current Ratio | 9.96% | 1.25% | 1.34% | 0% |
Quick Ratio | 0% | 0.92% | 1.18% | 0% |
Cash Position Ratio | 9.88% | 0.44% | 0.54% | 0% |
Liquididy | 50% | 12% | 9% | 55% |
Short-term ratios | ZURA | AMGN | GILD | BNTX |
---|---|---|---|---|
Return on equity | 0% | 0% | 0% | 0% |
Return on assets | -8.84% | 2.68% | 3.48% | 0% |
Return on sales | 0% | 21.68% | 28.93% | 0% |
Return on invested capital | 0% | 0% | 0% | 0% |
Profitability | 50% | 38% | 50% | 0% |
Total debt ratio | 18.5% | 92.96% | 66.32% | 0% |
Debt ratio change over time | 0% | 0% | 0% | 0% |
Dept financing | 30% | 25% | 18% | 0% |
Current Ratio | 9.96% | 1.25% | 1.34% | 0% |
Quick Ratio | 0% | 0.92% | 1.18% | 0% |
Cash Position Ratio | 9.88% | 0.44% | 0.54% | 0% |
Liquididy | 50% | 24% | 30% | 0% |